Browse by Clinical Topic:

Featured CME/CE Content:
neuroscienceCME Editors' Picks:

Case Challenge: Schizophrenia

neuroscienceCME Webcast

Premiere Date: Wednesday, August 19, 2015

This activity offers CE credit for:

  1. Physicians (CME)
  2. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Friday, August 19, 2016
Note: Credit Is No Longer Available


S. Charles Schulz, MDS. Charles Schulz, MD 
Professor and Head
Donald W. Hastings Endowed Chair
Department of Psychiatry
University of Minnesota Medical School
Minneapolis, MN

Henry A. Nasrallah, MDHenry A. Nasrallah, MD 
The Sydney W. Souers Endowed Chair
University of Cincinnati College of Medicine
Professor and Chairman, Department of Neurology and Psychiatry
Saint Louis University School of Medicine
St. Louis, MO

Statement of Need

This video is a replay of a plenary session from the 7th Annual Chair Summit Master Class for Neuroscience Professional Development held in Tampa Florida on September 11-13, 2014.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Individualize treatment for patients with schizophrenia by balancing the unique experiences of each patient with side effects, medical comorbidity, and medication adherence history.
  • Review the current data on treatment resistance in schizophrenia and consider all evidence-based pharmacological treatment options, even those that may require careful monitoring to improve patient care.
  • Devise a treatment plan with patient participation that includes measurement-based care including regular symptom assessment and metabolic monitoring for patients diagnosed with schizophrenia.

Financial Support

This activity is supported by an educational grant from Sunovion Pharmaceuticals Inc. and Jazz Pharmaceuticals, Inc.

Target Audience

Physicians, physician assistants, nurse practitioners, and other nonphysician health care professionals with an interest in psychiatry, neurology, and the neurosciences.

Credit Information

CME Credit (Physicians):
CME Credit (Physicians): CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

 CME Outfitters designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Post-tests, credit request forms, and activity evaluations must be completed online at (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Schulz has disclosed that he receives grants/research support from AstraZeneca Pharmaceuticals LP; Otsuka America Pharmaceutical, Inc.; Myriad Genetics Inc./Rules-Based Medicine, Inc.

Dr. Nasrallah has disclosed that he receives grants/research support from Otsuka America Pharmaceutical Inc.?PI Forum-- (PI Clinical Trials Funding Deposited at the University). He serves as a consultant to Boehringer Ingelheim; Merck & Co., Inc.; Otsuka America Pharmaceutical Inc.; Teva Pharmaceuticals; Sunovion Pharmaceuticals Inc. He is on the speakers bureau of Janssen Pharmaceuticals, Inc.; Lundbeck; Novartis Corporation; Otsuka America Pharmaceutical Inc.; Sunovion Pharmaceuticals Inc.

Disclosures were obtained from the CME Outfitters, LLC staff: Nothing to Disclose

Howard Bliwise, MD (peer reviewer) has no disclosures to report.

Robert Kennedy (planning committee) has no disclosures to report. 

Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.

Unlabeled Use Disclosure

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

CME Outfitters, LLC and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).


Home      |      Register/Log In      |      Activities      |      Communities of Practice      |      About      |      Download